COMPOSITIONS AND METHODS OF GENETIC MATERIAL DELIVERY

medicine, medicinal genetics. SUBSTANCE: method involves introduction of genetic material with enhancer of polynucleotide function (for example, bupivacaine) in cells of individual person. Molecules of nucleic acid no containing retrovirus particles are incorporated also. Nucleic acid molecule has t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VILL'JAM V. VILL'JAMS, BIN VANG, MAJKL DZH. MERVA, LESLI R. KONI, VINSENT R. ZURAVSKI ML, DEHVID B. VEJNER
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	medicine, medicinal genetics. SUBSTANCE: method involves introduction of genetic material with enhancer of polynucleotide function (for example, bupivacaine) in cells of individual person. Molecules of nucleic acid no containing retrovirus particles are incorporated also. Nucleic acid molecule has the sequence that encodes protein which involves at least one epitope identical or similar with antigen epitope being the latter is a target for immune response. This nucleotide sequence is bound operatively with regulatory sequences. Invention describes also a pharmaceutical composition and set for method realization. EFFECT: broadened arsenal of agents against HIV infection. 48 cl, 1 tbl, 19 dwg, 59 ex